Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer

NCT05451290 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Advanced Biliary Tract Carcinoma

Interventions

DRUG: Camrelizumab, apatinib, gemcitabine, oxaliplatin, tegafur

Sponsor

First Affiliated Hospital of Zhejiang University